CX3CL1 (fractalkine) and TNFα production by perfused human placental lobules under normoxic and hypoxic conditions in vitro: The importance of CX3CR1 signaling

Inflammation Research

Volumn 63, Issue 3, 2014, Pages 179-189

  Szukiewicz, Dariusz ^a   Kochanowski, Jan ^a   Mittal, Tarun Kumar ^a   Pyzlak, Michal ^a   Szewczyk, Grzegorz ^a   Cendrowski, Krzysztof ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

CX3CR1 expression; Fractalkine CX3CR1; Human placenta; Hypoxia; In vitro perfusion study; TNF

Indexed keywords

ADULT; ANOXIA; CAPILLARIES; CHEMOKINE CX3CL1; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LIPOPOLYSACCHARIDES; PERFUSION; PLACENTA; PREGNANCY; RECEPTORS, CHEMOKINE; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION; YOUNG ADULT;

EID: 84894428045     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-013-0687-z     Document Type: Article

References (43)

1. Myatt L. Control of vascular resistance in the human placenta. Placenta. 1992;13:329-41.
2. Hauguel-de Mouzon S, Guerre-Millo M. The placenta cytokine network and inflammatory signals. Placenta. 2006;27:794-8.
3. Steinke JW, Borish L. Cytokines and chemokines. J Allergy Clin Immunol. 2006;117(Suppl 2):441-5.
4. Raman D, Sobolik-Delmaire T, Richmond A. Chemokines in health and disease. Exp Cell Res. 2011;317:575-89.
5. Bazan JF, Bacon KB, Hardiman G, Wang W, Soo K, Rossi D, et al. A new class of membrane-bound chemokine with a CX3C motif. Nature. 1997;385:640-4.
6. Pan Y, Lloyd C, Zhou H, Dolich S, Deeds J, Gonzalo JA, et al. Neurotactin, a membrane-anchored chemokine upregulated brain inflammation. Nature. 1997;387:611-7.
7. Stievano L, Piovan E, Amadori A. C and CX3C chemokines: cell sources and physiopathological implications. Crit Rev Immunol. 2004;24:205-28.
8. Bowen JM, Chamley L, Mitchell MD, Keelan JA. Cytokines of the placenta and extra-placental membranes: biosynthesis, secretion and roles in establishment of pregnancy in women. Placenta. 2002;23:239-56.
9. Hannan NJ, Jones RL, White CA, Salamonsen LA. The chemokines, CX3CL1, CCL14, and CCL4, promote human trophoblast migration at the feto-maternal interface. Biol Reprod. 2006;74:896-904.
10. Hannan NJ, Salamonsen LA. CX3CL1 and CCL14 regulate extracellular matrix and adhesion molecules in the trophoblast: potential roles in human embryo implantation. Biol Reprod. 2008;79:58-65.
11. Yip L, McCluskey J, Sinclair R. Immunological aspects of pregnancy. Clin Dermatol. 2006;24:84-7.
12. Hunt JS. Stranger in a strange land. Immunol Rev. 2006;213:36-47.
13. Imai T, Hieshima K, Haskell C, Baba M, Nagira M, Nishimura M, et al. Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell. 1997;91:521-30.
14. Dogrell SA. CX3CR1 as a target for airways inflammation. Expert Opin Ther Targets. 2011;15:1139-42.
15. Chandrasekar B, Mummidi S, Perla RP, Bysani S, Dulin NO, Liu F, et al. Fractalkine (CX3CL1) stimulated by nuclear factor kappa B (NF-kappaB)-dependent inflammatory signals induces aortic smooth muscle cell proliferation through an autocrine pathway. Biochem J. 2003;373:547-58.
16. Sung MJ, Kim DH, Davaatseren M, Hur HJ, Kim W, Jung YJ, et al. Genistein suppression of TNF-alpha-induced fractalkine expression in endothelial cells. Cell Physiol Biochem. 2010;26:431-40.
17. Kim KW, Vallon-Eberhard A, Zigmond E, Farache J, Shezen E, Shakhar G, et al. In vivo structure/function and expression analysis of the CX3C chemokine fractalkine. Blood. 2011;118:e156-67.
18. Imaizumi T, Yoshida H, Satoh K. Regulation of CX3CL1/fractalkine expression in endothelial cells. J Atheroscler Thromb. 2004;11:15-21.
19. Ryu J, Lee CW, Hong KH, Shin JA, Lim SH, Park CS, et al. Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia. Cardiovasc Res. 2008;78:333-40.
20. Mehard B, Keane MP, Strieter RM. Chemokines as mediators of angiogenesis. Thromb Haemost. 2007;97:755-62.
21. Hempel SL, Monick MM, Hunninghake GW. Effect of hypoxia on release of IL-1 and TNF by human alveolar macrophages. Am J Respir Cell Mol Biol. 1996;14:170-6.
22. Yamashita K, Imaizumi T, Hatakeyama M, Tamo W, Kimura D, Kumagai M, et al. Effect of hypoxia on the expression of fractalkine in human endothelial cells. Tohoku J Exp Med. 2003;200:187-94.
23. van Meurs M, Wulfert FM, Jongman RM, Schipper M, Houwertjes MC, Vaneker M, et al. Hemorrhagic shock-induced endothelial cell activation in a spontaneous breathing and a mechanical ventilation hemorrhagic shock model is induced by a proinflammatory response and not by hypoxia. Anesthesiology. 2011;115:474-82.
24. Shimoya K, Zhang Q, Tenma K, Ota Y, Hashimoto K, Shizusawa Y, et al. Fractalkine (FRK) levels in amniotic fluid and its production during pregnancy. Mol Hum Reprod. 2003;9:97-101.
25. Schneider H, Challier JC, Dancis J. Transfer and metabolism of glucose and lactate in the human placenta studied by a perfusion system in vitro. Placenta. 1981;2(Suppl):129-38.
26. Szukiewicz D, Szukiewicz A, Maslinska D, Markowski M. In vitro effect of bioactive natriuretic peptides on perfusion pressure in placentas from normal and pre-eclamptic pregnancies. Arch Gynecol Obstet. 1999;263:37-41.
27. Szukiewicz D, Maslinska D, Gujski M, Pyzlak M, Klimkiewicz J, Stelmachow J. Angiotensin II (Ang II) evoked secretion of the human placental lactogen (HPL) in intrauterine growth retardation: examination of the relationship with Ang II receptor type 1 (AT1) expression. Int Immunopharmacol. 2008;8:177-81.
28. Szukiewicz D, Gujski M, Maslinska D, Szewczyk G, Bachanek M, Maslinski S. Mast cell-derived VEGF and VEGF receptor type 1, 2 and 3 expression in human term trophoblast culture - influence of hypoxia. Inflamm Res. 2005;54(Suppl 1):82-3.
29. Huppertz B, Abe E, Murthi P, Nagamatsu T, Szukiewicz D, Salafia C. Placental angiogenesis, maternal and fetal vessels - a workshop report. Placenta. 2007;28(Suppl A):94-6.
30. Kraus TA, Sperling RS, Engel SM, Lo Y, Kellerman L, Singh T, et al. Peripheral blood cytokine profiling during pregnancy and post-partum periods. Am J Reprod Immunol. 2010;64:411-26.
31. Umehara H, Bloom ET, Okazaki T, Nagano Y, Yoshie O, Imai T. Fractalkine in vascular biology: from basic research to clinical disease. Arterioscler Thromb Vasc Biol. 2004;24:34-40.
32. Cartwright JE, Keogh RJ, Tissot van Patot MC. Hypoxia and placental remodeling. Adv Exp Med Biol. 2007;618:113-26.
33. Keelan JA, Mitchell MD. Placental cytokines and preeclampsia. Front Biosci. 2007;12:2706-27.
34. Coussons-Read ME, Lobel M, Carey JC, Kreither MO, D'Anna K, Argys L, et al. The occurrence of preterm delivery is linked to pregnancy-specific distress and elevated inflammatory markers across gestation. Brain Behav Immun. 2012;26:650-9.
35. Kataoka T. Chemical biology of inflammatory cytokine signaling. J Antibiot (Tokyo). 2009;62:655-67.
36. Matsumiya T, Ota K, Imaizumi T, Yoshida H, Kimura H, Satoh K. Characterization of synergistic induction of CX3CL1/fractalkine by TNF-alpha and IFN-gamma in vascular endothelial cells: an essential role for TNF-alpha in post-transcriptional regulation of CX3CL1. J Immunol. 2010;184:4205-14.
37. Zhang J, Hu H, Palma NL, Harrison JK, Mubarak KK, Carrie RD, et al. Hypoxia-induced endothelial CX3CL1 triggers lung smooth muscle cell phenotypic switching and proliferative expansion. Am J Physiol Lung Cell Mol Physiol. 2012;303:L912-22.
38. Walenta KL, Bettink S, Böhm M, Friedrich EB. Differential chemokine receptor expression regulates functional specialization of endothelial progenitor cell subpopulations. Basic Res Cardiol. 2011;106:299-305.
39. Crola Da Silva C, Lamerant-Fayel N, Paprocka M, Mitterrand M, Gosset D, Dus D, et al. Selective human endothelial cell activation by chemokines as a guide to cell homing. Immunology. 2009;126:394-404.
40. Xiao LJ, Chen YY, Lin P, Zou HF, Zhao LN, Li D, et al. Hypoxia increases CX3CR1 expression via HIF-1 and NF-κB in androgen-independent prostate cancer cells. Int J Oncol. 2012;41:1827-36.
41. Kasama T, Wakabayashi K, Sato M, Takahashi R, Isozaki T. Relevance of the CX3CL1/fractalkine-CX3CR1 pathway in vasculitis and vasculopathy. Transl Res. 2010;155:20-6.
42. Lee SJ, Namkoong S, Kim YM, Kim CK, Lee H, Ha KS, et al. Fractalkine stimulates angiogenesis by activating the Raf-1/MEK/ERK- and PI3K/Akt/eNOS-dependent signal pathways. Am J Physiol Heart Circ Physiol. 2006;291:H2836-46.
43. Ahn SY, Cho CH, Park KG, Lee HJ, Lee S, Park SK, et al. Tumor necrosis factor-alpha induces fractalkine expression preferentially in arterial endothelial cells and mithramycin A suppresses TNF-alpha-induced fractalkine expression. Am J Pathol. 2004;164:1663-72.